Lv1
60 积分 2025-10-12 加入
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
8天前
已完结
STAT3, a Master Regulator of Anti-Tumor Immune Response
21天前
已完结
MHC-1 genotype as a predictor of response to immunotherapy
21天前
已关闭
Targeting the STAT3 pathway with STAT3 degraders
22天前
已完结
PARG inhibitor sensitivity correlates with accumulation of single- stranded DNA gaps in preclinical models of ovarian cancer
3个月前
已完结
PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy
3个月前
已完结
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
5个月前
已完结
皖公网安备34019202002308
